MedTrace Logo

Glutathione and Health With Post-Polio Syndrome

NCT01402570 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2017-02-17

Study results available
· View outcomes & findings →

Summary

In this study, people who have symptoms of post polio will take oral glutathione supplements for three months. Their levels of fatigue, physical activity and sleep efficiency will be assessed.

Conditions

  • Post-polio Syndrome
  • Physical Activity
  • Depression
  • Pain
  • Sleep Disorders

Interventions

DIETARY_SUPPLEMENT

Glutathione

glutathione is a dietary supplement and an antioxidant. Subjects will take 1000 mg per day for three month. Each capsule contains 500 mg glutathione.

Sponsors & Collaborators

Principal Investigators

  • Claire Kalpakjian, PhD, MS · University of Michigan

  • Mark Ziadeh, MD · University of Michigan

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2013-04-30
Completion
2013-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01402570 on ClinicalTrials.gov